{"slideshow_credits": null, "snippet": "Abbott Laboratories said it reached an agreement with the federal government and most states to pay $1.6 billion in connection with its marketing of the anti-seizure drug Depakote.", "abstract": "Abbott Laboratories says it reached an agreement with the federal government and most states to pay $1.6 billion in connection with its illegal marketing of the anti-seizure drug Depakote. (M)", "section_name": "Health; Business", "print_page": "1", "document_type": "article", "byline": {"person": [{"lastname": "SCHMIDT", "rank": 1, "firstname": "Michael", "role": "reported", "organization": "", "middlename": "S."}, {"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 2, "organization": ""}], "original": "By MICHAEL S. SCHMIDT and KATIE THOMAS"}, "web_url": "http://www.nytimes.com/2012/05/08/business/abbott-to-pay-1-6-billion-over-illegal-marketing.html", "lead_paragraph": "WASHINGTON -- The pharmaceutical company Abbott Laboratories said on Monday that it had reached an agreement with the federal and nearly all state governments to pay $1.6 billion in connection with its illegal marketing of the anti-seizure drug Depakote. The settlement comes as the Justice Department and the states have increased scrutiny of the sales and marketing practices of pharmaceutical companies, particularly in cases in which they market drugs for uses that are not approved by the Food and Drug Administration.", "headline": {"main": "Abbott Settles Marketing Lawsuit"}, "_id": "4fd2bbaa8eb7c8105d8b1b4e", "word_count": 662, "multimedia": [], "pub_date": "2012-05-07T00:00:00Z", "source": "The New York Times", "news_desk": "Business Day", "keywords": [{"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "organizations", "value": "ABBOTT LABORATORIES"}, {"name": "subject", "value": "SEIZURES (MEDICAL)"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "DEPAKOTE"}], "blog": [], "subsection_name": null, "type_of_material": "News"}